BACKGROUND: Greater levels of serum per- and polyfluoroalkyl substances (PFAS) are known to be associated with higher uric acid which itself leads to a number of chronic diseases. However, whether this association varies across PFAS isomers which recently have been found to be associated with human health remains unknown.

OBJECTIVES: To address this research gap, we explored isomer-specific associations between serum PFAS and uric acid in Chinese adults.

METHODS: We conducted a cross-sectional study of associations between serum PFAS isomer and serum uric acid in 1612 participants from the Isomer of C8 Health Project. We used multivariable linear and logistic regression models to analyze serum isomers of perfluorooctanoate (PFOA), perfluorooctane sulfonate (PFOS), and other PFASs as continuous and categorical predictors of uric acid, adjusted for confounders. The association was also stratified by kidney function stage based on estimated glomerular filtration rate (GF-1, GF-2, GF-3a, and GF-3b/4).

RESULTS: We found positive associations between serum PFAS isomer concentrations and uric acid. Uric acid levels were greater for each log-unit increase in branched PFOA (β = 0.30, 95% CI: 0.21, 0.40), linear PFOA (β = 0.18, 95% CI: 0.09, 0.26), branched PFOS (β = 0.09, 95% CI: 0.02, 0.17) and linear PFOS (β = 0.06, 95% CI: -0.01, 0.14) concentration. The associations between PFAS and uric acid showed an inverted 'U' shaped pattern across kidney function stages. For example, uric acid level was greater with each log-unit increase in total-PFOA among GF-1 (β = 0.21, 95% CI: 0.06, 0.37), this relationship was greater in GF-3a (β = 0.49, 95% CI: 0.09, 0.89) and decreased in GF-3b/4 (β = -0.22, 95% CI: -0.83, 0.39). We also found the odds of hyperuricemia increased linearly with increasing branched PFOA in quartiles (odds ratio = 2.67, 95% CI: 1.86, 3.85 at the highest quartile).

CONCLUSION: We report novel results in which PFAS associations with uric acid varied according to isomer and adult kidney function. Besides, our findings are consistent with previous epidemiologic studies in finding a positive association between serum PFAS concentrations and serum uric acid, especially for PFOA. Our results indicate that more research is needed to more clearly assess the impact of PFAS isomers on human health, which will help to refine regulation policies for PFAS.

[Untagged]
━ New Studies (6/2023)
━ ━ Met PECO
━ ━ ━ Human
━ ━ Supplemental
━ ━ ━ Mechanistic, including non-PECO routes of exposure
━ ━ ━ ADME
━ ━ ━ PFAS mixture
━ ━ ━ Exposure only
━ ━ ━ Ecotoxicity
━ ━ ━ Environmental fate or occurrence
━ ━ ━ Manufacturing, engineering or lab methods
━ ━ ━ Other assessments or records
━ ━ Excluded - Not Meeting PECO
━ Inclusion
━ ━ Human Study
━ ━ Animal Study
━ ━ In vitro (genotox)
━ Exclusion
━ ━ Tier I
━ ━ Tier III
━ PFAS
━ ━ PFBS
━ ━ PFNA
━ ━ PFDA
━ ━ PFHxS
━ ━ PFHxA
━ ━ PFBA
━ Health Outcome
━ ━ acute Toxicity/Poisoning
━ ━ ADME/toxicokinetic
━ ━ body weight
━ ━ cancer
━ ━ cardiovascular
━ ━ clinical chemistry/biochemical/cytotoxicity/cellular function
━ ━ endocrine (hormone)
━ ━ gastrointestinal
━ ━ gene expression/omics
━ ━ genotoxicity
━ ━ growth (early life) and development
━ ━ hematological
━ ━ hepatic
━ ━ immune/inflammation
━ ━ mortality
━ ━ musculoskeletal/motor function
━ ━ neurological/behavior
━ ━ nutrition and metabolic
━ ━ ocular and sensory
━ ━ PBPK model
━ ━ PPAR
━ ━ renal
━ ━ reproductive
━ ━ respiratory
━ ━ sensory
━ ━ skin and connective tissues
━ ━ susceptible population
━ ━ thyroid

References (517 found)